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Letter to the Editor
Seven-day subcutaneous continuous glucose
monitoring demonstrates that treatment with
acarbose attenuates late dumping syndrome in a
woman with gastrectomy for gastric cancer
Dear Editor,
Late dumping syndrome is a possible complication of upper
gastrointestinal surgery [1]. The symptoms occur one to three
hours after eating and include weakness, sweating, dizziness,
confusion, and loss of consciousness. These are a result of a
sudden increase in blood glucose due to the rapid passage of
carbohydrates into the small intestine and subsequent absorp-
tion, which causes excessive insulin secretion [2]. Diet with at
least 5 meals containing equal amounts of carbohydrates is the
treatment of choice, though symptoms may persist and require
pharmacologic treatment. It has been reported that a-glucosi-
dase inhibitors significantly ameliorate the neuroglycopenic
symptoms of late dumping syndrome [3–5]. In such cases,
monitoring glycemia with non-invasive subcutaneous contin-
uous glucose monitoring (SCGM) [6] may be useful for the
diagnosis and determining appropriate treatment.
We present the case of a 55-year-old woman (weight
56.5 kg; BMI 21.8 kg/m2) who underwent gastrectomy for
gastric cancer in 2010. Type 2 diabetes was diagnosed in
2006 and she was treated with sulfonylurea which was
discontinued after gastrectomy. Following surgery, severe
symptoms of blurred vision, diaphoresis, confusion and
episodic loss of consciousness occurred one to three hours
after eating, and were related to low capillary blood glucose
levels. Late dumping syndrome was diagnosed and she was
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Fig. 1 – Seven-day evolution of glycemia evaluated by subcutaneous continuous glucose monitoring in a gastrectomized
woman with late dumping syndrome before (A) and after (B) treatment with acarbose.
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referred to our hospital. Treatment with acarbose 25 mg before
breakfast, lunch, and dinner was started. 7-Day SCGM (ENLITE
Glucose Sensor; Medtronic Minimed, Northridge, CA, USA)
was performed before and soon after treatment with acarbose
and average 7-day glycemia, standard deviation, coefficient of
variability (CV%), number of hypoglycemic (glycemia < 70 mg/
dl) or hyperglycemic (glycemia > 140 mg/dl) events was
calculated (Fig. 1) [7]. During therapy with acarbose, there
was a significant improvement in symptoms and no episode of
loss of consciousness. Before acarbose treatment, average 7-
day glycemia (mean  SD) was 91  37 mg/dl, with 28% of
values in the hypoglycemia range, and 11% above the
hyperglycemic threshold; CV was 40.7%. After acarbose
treatment, 7-day glycemia was 99  34 mg/dl, with 10% of
values in the hypoglycemia range and 17% above the
hyperglycemic threshold; CV was 34.3%. Therefore acarbose
reduced the incidence of hypoglycemia, ameliorated the late
dumping symptoms but increased the duration of hypergly-
cemia. A previous report [8] has documented favorable effects
of acarbose on late dumping syndrome with CSGM in a patient
who had undergone bariatric surgery. Our case report provides
further evidence of successful medical treatment of late
dumping syndrome with acarbose and highlights the useful-
ness of SCGM as an investigative tool.
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